NCT03010358
- Conditions
- Anemia, B-Cell Prolymphocytic Leukemia, Chronic Disease, +36 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
Clinical trial condition
Grade 3a Follicular Lymphoma
Explore clinical trials studying Grade 3a Follicular Lymphoma. Study availability and eligibility vary by location and protocol.
22 public trials
4 recruiting studies
Grade 3a Follicular Lymphoma trial results
Completed
Pembrolizumab and Ibrutinib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
NCT02950220
- Conditions
- B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +46 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States